High-normal thyroid function and risk of recurrence of atrial fibrillation after catheter ablation

Circulation Journal

Volumn 74, Issue 7, 2010, Pages 1317-1321

  Tang, Ri Bo ^a   Liu, Dong Ling ^a   Dong, Jian Zeng ^a   Liu, Xing Peng ^a   Long, De Yong ^a   Yu, Rong Hui ^a   Hu, Fu Li ^b   Wu, Jia Hui ^a   Liu, Xiao Hui ^a   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HEBEI GENERAL HOSPITAL   (China)

Author keywords

Atrial fibrillation; Catheter ablation; Recurrence; Thyroid

Indexed keywords

THYROTROPIN; THYROXINE; DRUG DERIVATIVE; THYROXINE SULFATE;

ADULT; ARTICLE; CATHETER ABLATION; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PULMONARY VEIN; RECURRENCE RISK; THYROID FUNCTION; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL; AGED; BLOOD; FOLLOW UP; MIDDLE AGED; OBSERVATION; PATHOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; RECURRENT DISEASE; RISK; THYROID GLAND;

ADULT; AGED; ATRIAL FIBRILLATION; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OBSERVATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; PULMONARY VEINS; RECURRENCE; RISK; THYROID GLAND; THYROXINE;

EID: 77954552821     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.cj-09-0708     Document Type: Article

References (26)

1. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001; 142: 838-842.
2. Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: A population-based study. Arch Intern Med 2004; 164: 1675-1678.
3. Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007; 167: 928-934.
4. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, et al. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-e354.
5. Ma CS, Liu X, Hu FL, Dong JZ, Liu XP, Wang XH, et al. Catheter ablation of atrial fibrillation in patients with hyperthyroidism. J Interv Card Electrophysiol 2007; 18: 137-142.
6. Liu X, Dong J, Mavrakis HE, Hu F, Long D, Fang D, et al. Achievement of pulmonary vein isolation in patients undergoing circumferential pulmonary vein ablation: A randomized comparison between two different isolation approaches. J Cardiovasc Electrophysiol 2006; 17: 1263-1270.
7. Tang RB, Dong JZ, Liu XP, Long DY, Yu RH, Kalifa J, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J 2009; 73: 438-443.
8. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993; 87: 1435-1441.
9. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992; 327: 94-98.
10. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331: 1249-1252.
11. Tenerz A, Forberg R, Jansson R. Is a more active attitude warranted in patients with subclinical thyrotoxicosis? J Intern Med 1990; 228: 229-233.
12. Johnson PN, Freedberg AS, Marshall JM. Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. Cardiology 1973; 58: 273-289.
13. Sun ZQ, Ojamaa K, Coetzee WA, Artman M, Klein I. Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. Am J Physiol Endocrinol Metab 2000; 278: E302-E307.
14. Dixit S, Gerstenfeld EP, Ratcliffe SJ, Cooper JM, Russo AM, Kimmel SE, et al. Single procedure efficacy of isolating all versus arrhythmogenic pulmonary veins on long-term control of atrial fibrillation: A prospective randomized study. Heart Rhythm 2008; 5: 174-181.
15. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998; 339: 659-666.
16. Chen YC, Chen SA, Chen YJ, Chang MS, Chan P, Lin CI. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol 2002; 39: 366-372.
17. Fazio S, Palmieri EA, Lombardi G, Biondi B. Effects of thyroid hormone on the cardiovascular system. Recent Prog Horm Res 2004; 59: 31-50.
18. Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: The Rotterdam study. Arch Intern Med 2008; 168: 2219-2224.
19. Sgarbi JA, Villaca FG, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endo-crinol Metab 2003; 88: 1672-1677.
20. Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Marchlinski FE. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006; 3: 1024-1028.
21. Pappone C, Rosanio S, Augello G, Gallus G, Vicedomini G, Mazzone P, et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: Outcomes from a controlled nonrandomized long-term study. J Am Coll Cardiol 2003; 42: 185-197.
22. Zimetbaum P. Amiodarone for atrial fibrillation. N Engl J Med 2007; 356: 935-941.
23. Turco P, De Simone A, La Rocca V, Iuliano A, Capuano V, Astarita C, et al. Antiarrhythmic drug therapy after radiofrequency catheter ablation in patients with atrial fibrillation. Pacing Clin Electro-physiol 2007; 30(Suppl 1): S112-S115.
24. Yamada T, Yoshida N, Murakami Y, Okada T, Yoshida Y, Muto M, et al. Vagal modification can be a valid predictor of late recurrence of paroxysmal atrial fibrillation independent of the pulmonary vein isolation technique. Circ J 2009; 73: 1606-1611.
25. Noguchi H, Kumagai K, Yasuda T, Ogawa M, Tojo H, Saku K. Conduction recovery after pulmonary vein isolation for atrial fibrillation. Circ J 2005; 69: 65-68.
26. Oral H, Veerareddy S, Good E, Hall B, Cheung P, Tamirisa K, et al. Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation. J Cardiovasc Electro-physiol 2004; 15: 920-924.